Malnutrition is associated with poor outcomes in critically ill patients, and providing enteral feeding to those who cannot eat is considered best practice. Enteral feeding is often unsuccessful when there is delayed gastric emptying. Recent research has given additional insight into the mechanisms underlying delayed gastric emptying. Pharmacological strategies to improve the success of feeding include prokinetic drugs such as metoclopramide and erythromycin alone or in combination. When drug treatment fails, either parenteral nutrition or direct small intestinal feeding is indicated. Simpler methods to access the duodenum and distal small bowel for feed delivery are under investigation. This review summarizes current understanding of the mechanisms underlying enteral feeding intolerance in critical illness, together with the evidence for current treatment practices. Areas requiring further research are also described.
McClaveSASextonLKSpainDA. Enteral tube feeding in the intensive care unit: factors impeding adequate delivery. Crit Care Med. 1999;27:1252-1256.
2.
De BeauxChapmanMFraserR. Enteral nutrition in the critically ill: a prospective survey in an Australian intensive care unit. Anaesth Intensive Care. 2001;29:619-622.
3.
JonesDGeorgeCHartGKBellomoRMartinJ. Introduction of medical emergency teams in Australia and New Zealand: a multi-centre study. Crit Care. 2008;12:R46.
4.
VilletSChioleroRLBollmannMD. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 2005;24:502-509.
5.
KangWKudskKA. Is there evidence that the gut contributes to mucosal immunity in humans?JPEN J Parenter Enteral Nutr. 2007;31:246-258.
6.
CookDJWalterSDCookRJ. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433-440.
7.
NguyenNQFraserRJBryantLKHollowayRH. Functional association between proximal and distal gastric motility during fasting and duodenal nutrient stimulation in humans. Neurogastroenterol Motil. 2007;19:638-645.
8.
HorowitzMDentJFraserRSunWHebbardG. Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci. 1994;39(12 suppl):7S-13S.
9.
HeddleRCollinsPJDentJ. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion. J Gastroenterol Hepatol. 1989;4:437-447.
10.
HauskenTGiljaOHOdegaardSBerstadA. Flow across the human pylorus soon after ingestion of food, studied with duplex sonography: effect of glyceryl trinitrate. Scand J Gastroenterol. 1998;33:484-490.
11.
VozzoRSuYCFraserRJ. Antropyloroduodenal, cholecystokinin and feeding responses to pulsatile and non-pulsatile intraduodenal lipid infusion. Neurogastroenterol Motil. 2002;14:25-33.
12.
VantrappenGJanssensJHellemansJGhoosY. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977;59:1158-1166.
13.
DiveAMoulartMJonardPJamartJMahieuP. Gastroduodenal motility in mechanically ventilated critically ill patients: a manometric study. Crit Care Med. 1994;22:441-447.
14.
DiveAMiesseCJamartJEvrardPGonzalezMInstalleE. Duodenal motor response to continuous enteral feeding is impaired in mechanically ventilated critically ill patients. Clin Nutr. 1994;13:302-306.
15.
NguyenNQFraserRJChapmanM. Proximal gastric response to small intestinal nutrients is abnormal in mechanically ventilated critically ill patients. World J Gastroenterol. 2006;12:4383-4388.
16.
ChapmanMFraserRVozzoR. Antro-pyloro-duodenal motor responses to gastric and duodenal nutrient in critically ill patients. Gut. 2005;54:1384-1390.
17.
NguyenNQFraserRJChapmanMJ. Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrations. Crit Care Med. 2007;35:82-88.
18.
NguyenNQFraserRJChapmanM. Fasting and nutrient-stimulated plasma peptide-YY levels are elevated in critical illness and associated with feed intolerance: an observational, controlled study. Crit Care. 2006;10:R175.
19.
DeaneAChapmanMJFraserRJBryantLKBurgstadCNguyenNQ. Mechanisms underlying feed intolerance in the critically ill: implications for treatment. World J Gastroenterol. 2007;13:3909-3917.
20.
MacLarenRKiserTHFishDNWischmeyerPE. Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. JPEN J Parenter Enteral Nutr. 2008;32:412-419.
21.
NguyenNQChapmanMJFraserRJBryantLKHollowayRH. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med. 2007;35:483-489.
22.
RhoneyDHParkerDJrFormeaCMYapCCoplinWM. Tolerability of bolus versus continuous gastric feeding in brain-injured patients. Neurol Res. 2002;24:613-620.
23.
JanssensJPeetersTLVantrappenG. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990;322:1028-1031.
24.
SarnaSKSoergelKHKochTR. Gastrointestinal motor effects of erythromycin in humans. Gastroenterology. 1991;101:1488-1496.
25.
FraserRShearerTFullerJHorowitzMDentJ. Intravenous erythromycin overcomes small intestinal feedback on antral, pyloric, and duodenal motility. Gastroenterology. 1992;103:114-119.
26.
ChapmanMJFraserRJKlugerMTBuistMDDe NichiloDJ. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Crit Care Med. 2000;28:2334-2337.
27.
RitzMAChapmanMJFraserRJ. Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill. Intensive Care Med. 2005;31:949-954.
28.
BerneJDNorwoodSHMcAuleyCE. Erythromycin reduces delayed gastric emptying in critically ill trauma patients: a randomized, controlled trial. J Trauma. 2002;53:422-425.
29.
DepoortereIPeetersTLVantrappenG. Effect of erythromycin and of octreotide on motilin receptor density in the rabbit. Regul Pept. 1991;32:85-94.
30.
NguyenNFraserRBryantL. Plasma erythromycin concentrations predict feeding outcomes in critically ill patients with feed intolerance [abstract]. Gastroenterology. 2009;136(suppl 1):A-537.
31.
MittalRKFrankEBLangeRCMcCallumRW. Effects of morphine and naloxone on esophageal motility and gastric emptying in man. Dig Dis Sci. 1986;31:936-942.
32.
NguyenNQChapmanMJFraserRJ. The effects of sedation on gastric emptying and intra-gastric meal distribution in critical illness. Intensive Care Med. 2008;34:454-460.
33.
MeissnerWDohrnBReinhartK. Enteral naloxone reduces gastric tube reflux and frequency of pneumonia in critical care patients during opioid analgesia. Crit Care Med. 2003;31: 776-780.
34.
GonenneJCamilleriMFerberI. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol. 2005;3:784-791.
35.
BuchlerMWSeilerCMMonsonJR. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study. Aliment Pharmacol Ther. 2008;28:312-325.
36.
RobertsDJBanhHLHallRI. Use of novel prokinetic agents to facilitate return of gastrointestinal motility in adult critically ill patients. Curr Opin Crit Care. 2006;12:295-302.
37.
NguyenNQChapmanMFraserRJBryantLKBurgstadCHollowayRH. Prokinetic therapy for feed intolerance in critical illness: one drug or two?Crit Care Med. 2007;35:2561-2567.
38.
BortolottiMMariCBrunelliFSartiPMiglioliM. Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. Dig Dis Sci. 1999;44:2439-2442.
39.
HawkyardCVKoernerRJ. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. J Antimicrob Chemother. 2007;59:347-358.
40.
KatapadiKKostandyGKatapadiMHussainKMSchifterD. A review of erythromycin-induced malignant tachyarrhythmia—torsade de pointes. A case report. Angiology. 1997;48:821-826.
41.
TalleyNJVerlindenMSnapeW. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000;14:1653-1661.
42.
TougasGBovellKTCollinsSMDentJHuntRH. The effect of naloxone on lipid-induced pyloric motor response in humans. Gastroenterology. 1990;99:930-934.
43.
SchwizerWBorovickaJKunzP. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut. 1997;41:500-504.
44.
PeetersTL. Central and peripheral mechanisms by which ghrelin regulates gut motility. J Physiol Pharmacol. 2003;54(suppl 4):95-103.
